Show simple item record

dc.contributor.authorWorld Health Organizationen_US
dc.coverage.spatialGenevaen_US
dc.date.accessioned2018-04-30T14:26:17Z
dc.date.available2018-04-30T14:26:17Z
dc.date.issued2018
dc.identifier.isbn9789241550284
dc.identifier.urihttps://iris.who.int/handle/10665/272433
dc.description68 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.rightsCC BY-NC-SA 3.0 IGOen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0/igoen_US
dc.subjectWHO guideline
dc.subject.meshDiabetes Mellitusen_US
dc.subject.meshBlood Glucoseen_US
dc.subject.meshInsulinen_US
dc.subject.meshAdulten_US
dc.subject.meshGuidelineen_US
dc.titleGuidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitusen_US
dc.typePublicationsen_US
dc.subject.meshqualifierdrug therapyen_US
dc.rights.holderWorld Health Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record